Incidence and Risk Factors for Adjacent Segment Disease After Transforaminal Lumbar Interbody Fusion in Patients with Lumbar Degenerative Diseases
Jiawen Ye,Sizhen Yang,Zihan Wei,Chenhui Cai,Ying Zhang,Hao Qiu,Tongwei Chu
DOI: https://doi.org/10.2147/IJGM.S337298
IF: 2.145
2021-11-16
International Journal of General Medicine
Abstract:Jiawen Ye, Sizhen Yang, Zihan Wei, Chenhui Cai, Ying Zhang, Hao Qiu, Tongwei Chu Department of Orthopedics, Xinqiao Hospital, Army Medical University, Chongqing, People's Republic of China Correspondence: Tongwei Chu Department of Orthopedics, Xinqiao Hospital, Army Medical University, Shapingba District, Chongqing, People's Republic of China Tel +86 13708388336 Email Purpose: To explore the incidence and risk factors for adjacent segment disease (ASD) in patients with lumbar degenerative diseases after transforaminal lumbar interbody fusion (TLIF). Patients and Methods: The clinical data of 1258 patients who underwent transforaminal lumbar interbody fusion (TLIF) for lumbar degenerative diseases in our hospital from January 2011 to December 2017 were retrospectively analyzed. Patients were divided into the ASD group and non-ASD (N-ASD) group, and the incidence of ASD was calculated. We compared age, BMI, comorbidities, surgery-related parameters, and imaging parameters before surgery between the two groups and used univariate analysis and logistic regression analysis to explore the risk factors for ASD. Results: Among the 1258 patients who underwent TLIF due to lumbar degenerative diseases, 65 patients developed ASD and received surgical treatment for it, for an incidence of 5.2%. The average onset time of ASD was 68.3± 25.1 (20– 123) months. Univariate analysis showed that BMI, hypertension, preoperative adjacent segment disc degeneration and preoperative adjacent intervertebral disc height were significantly different between the ASD and N-ASD groups (P< 0.05). Incorporating the above indicators into the logistic regression model, the results showed that BMI and preoperative adjacent intervertebral disc degeneration were risk factors for ASD after TLIF. Conclusion: The incidence of ASD after TLIF in patients with lumbar degenerative disease is approximately 5.2%. High BMI and preoperative adjacent segment disc degeneration are risk factors for ASD after TLIF. Keywords: lumbar degenerative disease, transforaminal lumbar interbody fusion, adjacent segment disease, risk factors With the acceleration of demographic aging, the incidence of lumbar degenerative diseases is approximately 3.36% 1 worldwide and is on the rise. Posterior lumbar interbody fusion (PLIF) is one of the classic surgical procedures for lumbar degenerative diseases. 2 It can achieve stable intervertebral fusion and sufficient nerve structure decompression, 3 thus significantly relieving the symptoms. Transforaminal lumbar interbody fusion (TLIF) can preserve more posterior structures while achieving the above-mentioned surgical effects and maintaining the biomechanical stability of the spine, 4,5 so TLIF is increasingly used to treat lumbar degenerative diseases. Although most patients have alleviated symptoms and improved quality of life after lumbar fusion, the biomechanical changes in the spine caused by fusion may accelerate the degeneration of adjacent segments. Adjacent segment disease (ASD) is a potential long-term complication after lumbar fusion. 6 In different studies, due to the different definitions of ASD, the incidence of ASD after lumbar fusion has ranged from 5.0% to 49%. 7–11 The risk factors for ASD after lumbar fusion are still controversial, and there have been few articles on ASD after TLIF using the same technique with a large number of case follow-ups. To the best of our knowledge, there have been only 2 articles with more than 1000 cases. 10,12 This study aims to explore the incidence of ASD and its risk factors in patients with lumbar degenerative diseases after TLIF with the hope of reducing the incidence of ASD. This study complied with the Declaration of Helsinki and was approved by the ethics committee of Xinqiao Hospital of Army Medical University. All patients signed an informed consent form. A total of 1258 patients with lumbar degenerative disease treated by TLIF performed by the same surgeon in our department from January 2011 to December 2017 were included. They were 566 males and 692 females with an average age of 56.4 ±12.4 years. Inclusion criteria: clinical diagnosis of lumbar degenerative disease, including lumbar disc herniation (LDH), degenerative spondylolisthesis (DS), isthmic spondylolisthesis (SO), and lumbar spinal stenosis (LSS); TLIF treatment; complete preoperative and postoperative imaging data; follow-up time ≥24 months; and ≤2 fusion segments. Exclusion criteria: age <18 years; complications with spinal fractures, tumors, infections, ankylosing spondylitis or other spinal diseases; previous history of lumbar fusion surgery; and scoliosis with a Cobb angle ≥ 20°. In this study, ASD was defined as a symptomatic dege -Abstract Truncated-
medicine, general & internal